Get the Stockscreener App
10.58
0.09%
0.010
After Hours:
10.58
Drugs Made In America Acquisition Corp stock is traded at $10.58, with a volume of 1,666.
It is up +0.09% in the last 24 hours and up +0.67% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.57
Open:
$10.56
24h Volume:
1,666
Relative Volume:
0.01
Market Cap:
$356.73M
Revenue:
-
Net Income/Loss:
$5.94M
P/E Ratio:
59.71
EPS:
0.1772
Net Cash Flow:
$-539.20K
1W Performance:
+0.19%
1M Performance:
+0.67%
6M Performance:
+2.52%
1Y Performance:
+4.65%
1-Day Range:
$10.56
$10.60
1-Week Range:
$10.53
$10.60
52-Week Range:
$10.07
$10.60
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
646-726-7074
Address
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs LION, XXI, UMAC, DMII, BCSS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.58 | 356.39M | 0 | 5.94M | -539.20K | 0.1772 |
LION
Lionsgate Studios Corp
|
12.60 | 3.66B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
8.97 | 3.08B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
13.59 | 659.94M | 11.20M | -19.19M | -23.24M | -0.7527 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.01 | 637.96M | 0 | 4.19M | 0 | 0.065 |
BCSS
Bain Capital Gss Investment Corp
|
10.15 | 593.05M | 0 | 0 | 0 | 0.0729 |
Drugs Made In America Acquisition Corp Stock (DMAA) Latest News
Drugs Made In America Acquisition Corp (DMAA) and Power Analytics Global Corp Announce Definitive $1B AI Merger Agreement - Minichart
Drugs Made In America Acquisition Announces PAGC Merger Deal - TipRanks
DMAA (NASDAQ: DMAA) sets $1.0B PAGC merger with 90/10 ownership split - Stock Titan
Leadership Compensation Aligned With Future Business Combination - TipRanks
Shareholders Approve Extension of SPAC Business Combination Deadline - The Globe and Mail
DMAA Corp Extends Business Combination Deadline to April 29, 2027 Following Shareholder Approval – SEC 8-K Filing Update - Minichart
Drugs Made in America (NASDAQ: DMAA) holders redeem $99M from SPAC trust - Stock Titan
Talon Resources plc: Shareholders Board Members Managers and Company Profile | GB00BM8SQP62 - marketscreener.com
Drugs Made In America Acquisition Updates Executive Compensation Agreements - The Globe and Mail
Drugs Made In America Acquisition II Corp. Updates CFO and CEO Compensation Agreements and Share Grant Terms - Minichart
[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event - Stock Titan
Drugs Made in America (NASDAQ: DMAA) details new CEO pay deal - Stock Titan
AmericanDrug (DMAAR) Stock: This Week (-4.28%) 2026-04-27Macro Trends - Newser
ETFs Investing in Drugs Made In America Acquisition II Corp. Stocks - TradingView
Short Interest in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Grows By 8,397.5% - MarketBeat
DMAA | Drugs Made In America Insider Trading - Quiver Quantitative
Illumination Acquisition Corp I: Performance & Quotes, ILLU Stock Price on Nasdaq Exchange - marketscreener.com
DMII Price History for Drugs Made IN America Acquisition II Stock - Barchart.com
DMAAR Price History for Drugs Made IN America Acquisition Corp. Rights Stock - Barchart.com
USDrugAcqII (DMIIU) Stock Mutual Fund Trade (+0.10%) 2026-04-20Market Hype - Cổng thông tin điện tử tỉnh Lào Cai
AmDrug Acq2 (DMII) Stock: Is It a Compelling Buy (Idled) 2026-04-20Rating Change - Cổng thông tin điện tử tỉnh Lào Cai
Is AmericanDrug (DMAAR) stock exposed to downside risk (Selloff Intensifies) 2026-04-20Company Analysis - Cổng thông tin điện tử tỉnh Lào Cai
US Drug Acq (DMAA) Stock Upgrade Alert (Stuck) 2026-04-18Expert Breakout Alerts - Xã Châu Thành
Drugs Made In America Acquisition Corp.: Valuation Ratios, Analysts' Forecasts - marketscreener.com
Vote math updated for Drugs Made In America (DMAA) in proxy amendment - Stock Titan
Drugs Made In America Acquisition II Corp. 10-K Annual Report: Business Strategy, Acquisition Focus, and Management Overview - Minichart
Drugs Made In America Acquisition Corp. (DMAA): SPAC Focusing on AI, Machine Learning, and Pharmaceutical Acquisition Opportunities - Minichart
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Drugs Made In America (NASDAQ: DMAA) details SPAC cash, LOI and risks - Stock Titan
Drugs Made In America Acquisition II Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Drugs Made In America Acquisition II (DMII) logs $4.2M income, flags going-concern risk - Stock Titan
Paloma Acquisition Corp I: Performance & Quotes, PALO Stock Price on Nasdaq Exchange - marketscreener.com
Drugs Made in America (DMAA) asks investors to extend SPAC deal deadline - Stock Titan
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Sees Large Decrease in Short Interest - MarketBeat
Drugs Made In America Acquisition II Corp. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Chipmakers Recap: Can Drugs Made In America Acquisition Corp Equity Right sustain earnings growth2026 Performance Recap & Daily Entry Point Trade Alerts - baoquankhu1.vn
Weekly Recap: Is Drugs Made In America Acquisition Corp a momentum stock2026 Stock Rankings & High Conviction Trade Alerts - baoquankhu1.vn
JPMorgan Chase & Co. Buys Shares of 99,690 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Aug Chart Watch: What makes Drugs Made In America Acquisition Corp stock attractive today2026 Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%What's Next? - MarketBeat
Targets Report: Can Drugs Made In America Acquisition Corp Equity Right deliver alphaStop Loss & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Drugs Made In America Acquisition Corp.Rights (NQ: DMAAR - The Chronicle-Journal
Drugs Made In America Acquisition Corp. Signs LOI for De-SPAC Merger with Power Analytics Global Corp - Minichart
Power Analytics Global Corp signed a letter of intent to acquire Drugs Made In America Acquisition Corp. in a reverse merger transaction for $1.0 billion. - marketscreener.com
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Competitors - Meyka
Drugs Made in America SPAC Signs Power Analytics LOI - TipRanks
Drugs Made in America Acquisition Corp. signs LOI for de-SPAC with Power Analytics - Investing.com
Drugs Made In America Acquisition CorpEnters Loi For De-Spac With Power Analytics Global CorpSEC Filing - TradingView
Drugs Made in America to pursue de-SPAC with Power Analytics Global at ~$1.0B valuation - TradingView — Track All Markets
De-SPAC LOI values Power Analytics at $1.0B with DMAA (NASDAQ: DMAA) - Stock Titan
Idea Acquisition Corp.: Performance & Quotes, IACO Stock Price on Nasdaq Exchange - marketscreener.com
Drugs Made In America Acquisition Corp Stock (DMAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):